At twoXAR, we discover drugs using artificial intelligence. We are seeking a translational scientist to bridge our in silico predictions and the preclinical proof of concept studies. The ideal candidate has a PhD from a top-tier school with a concentration in drug discovery or pharmacology and at least five years of experience at a biotech/pharma in translational science. If you’re frustrated with the lack of control and found the pace too slow at a big company, we are just what you may be seeking.
This Palo Alto-based role is part of our core team and is critical to our success; compensation (including stock options) reflects the importance of this role and is commensurate with experience. Our benefits are competitive with the market. You will be in good company with entrepreneurs who have built systems used by tens of millions of people, held VP level-positions at Fortune 100 companies, and have had former startups end with successful sales to strategic acquirers.
twoXAR is an artificial intelligence-driven drug discovery company
We leverage our computational platform to identify promising drug candidates, validate and de-risk them through preclinical studies, and progress candidates to the clinic through industry and investor partnerships with the intent to exit assets to sale at any stage. In 2015, we raised seed financing from Andreessen Horowitz and spent 2016 running successful in vivo proof-of concept studies across multiple diseases. We have established collaborations with leading bio/pharmaceutical companies and are now scaling our business and building our internal drug pipeline.